However, using extensive morphometric analyses, our study clearly shows that the growth-inhibiting effect in RMS is solely based on the increase of apoptosis in BA-treated tumours leaving CD31-positive microvessel density, Ki-67-based proliferation index, and differentiation status unaffected. The gene discussed is PECAM1; the disease is neoplasm.